Search results

• 2009

  LY466195, a clinically active compound in the acute treatment of migraine, inhibits activation in the trigeminocervical complex and the ventroposteromedial thalamus after nociceptive trigeminovascular activation

  Andreou, A. P. & Goadsby, P. J., Oct 2009, In: Cephalalgia. 29, p. 132-132 1 p.

  Research output: Contribution to journal › Poster abstract › peer-review

• Sodium valproate but not gabapentin modulates trigeminovascular nociceptive transmission in the thalamus via GABA(A) receptor mechanisms: implications for migraine

  Andreou, A. P., Shields, K. G. & Goadsby, P. J., Oct 2009, In: Cephalalgia. 29, p. 140-140

  Research output: Contribution to journal › Poster abstract › peer-review